The administration of the 3rd dose of the Covid-19 vaccine to persons 12 years of age and older who are severely immunocompromised was decided by the National Advisory Committee on Vaccination of the Ministry of Health, after evaluating the data and reports of the European Medicines Agency.
As stated in a statement, Moderna and Pfizer vaccines (3rd dose) may be administered at least 28 days after the 2nd dose to persons 12 years of age and older who are severely immunocompromised.
Severely immunocompromised persons are defined as persons:
With solid organ transplantation, or hematopoietic cell transplantation.
CNA
Contents of this article including associated images are owned by CNA
Views & opinions expressed are those of the author and/or CNA
Source
